• Users Online: 98
  • Print this page
  • Email this page
Ahead of Print

Atropine: Updates on myopia pharmacotherapy

 Department of Ophthalmology, Yerevan State Medical University, Yerevan, Armenia

Correspondence Address:
Marianne L Shahsuvaryan,
Department of Ophthalmology, Yerevan State Medical University, Yerevan
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/2211-5056.354535

The prevalence of myopia has rapidly increased over the last 30 years, with the World Health Organization estimating a worldwide incidence of 23%, projected to increase to 50% by 2050. The myopia epidemic has prompted a reincarnation in efforts to overcome this challenge. The exploration of atropine use in myopia was a result due to a lack of treatment in effect. This study aimed at reviewing the role of atropine in the management of myopia worldwide based on currently available findings. A literature search was conducted using PubMed/MEDLINE and Google Scholar for studies published up to April 2022 inclusive. Articles with high or medium clinical relevance were selected for this review. Multiple studies have demonstrated the relevance and efficacy rates of different concentrations of atropine, despite still insufficiently explained the exact site and mechanism of action of atropine in slowing myopia progression. Currently available findings highlight that topical atropine opened a new page in pharmacotherapy of myopia and have shown a high therapeutic effect on myopia progression in Asian and European child population, irrespective of ethnicity. There is potential for myopia control with fewer side effects using lower concentrations but still exists a room for improvement, underscoring the requirement of modified atropine topical preparations with increased bioavailability, potentially with nanoparticle formulations, to enable the effective management of myopia.

Print this article
  Search Pubmed for
    -  Shahsuvaryan ML
 Citation Manager
 Article Access Statistics
 Reader Comments
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded12    

Recommend this journal